Fund Holdings — Pennant Investors, LP

Total Portfolio Value:
$325.45M
Total Bought:
$52.16M
Total Sold:
$24.32M
Net Transaction:
+$27.84M
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Amazon.com, Inc.(AMZN)348,000348,0000$44.24M$52.88M16.25%+$8.64M
Alphabet Inc.CL A(GOOG)375,000375,0000$49.07M$52.38M16.10%+$3.31M
Microsoft Corporation(MSFT)129,000129,0000$40.73M$48.51M14.91%+$7.78M
TransDigm Group Incorporated(TDG)42,00042,0000$35.41M$42.49M13.06%+$7.08M
EchoStar CorporationCL A(ECHO)02,153,209+2,153,209$0$35.68M10.96%+$35.68M
Micron Technology, Inc.(MU)306,000306,0000$20.82M$26.11M8.02%+$5.30M
The Odp Corp400,000400,0000$18.46M$22.52M6.92%+$4.06M
Antero Resources Corporation(AR)913,000913,0000$23.17M$20.71M6.36%-$2.47M
Perimeter Solutions, Inc.(PRM)1,600,0002,300,000+700,000$7.26M$10.58M3.25%+$3.32M
Altimmune, Inc.(ALT)0109,800+109,800$0$1.24M0.38%+$1.24M
Fibrogen Inc0768,400+768,400$0$681.0K0.21%+$681.0K
Nurix Therapeutics, Inc.(NRIX)056,800+56,800$0$586.2K0.18%+$586.2K
Coherus Oncology, Inc.(CHRS)0168,100+168,100$0$559.8K0.17%+$559.8K
Arcutis Biotherapeutics, Inc.(ARQT)0170,900+170,900$0$552.0K0.17%+$552.0K
Fate Therapeutics, Inc.(FATE)0146,100+146,100$0$546.4K0.17%+$546.4K
Igm Biosciences Inc064,900+64,900$0$539.3K0.17%+$539.3K
Allakos Inc0186,100+186,100$0$508.1K0.16%+$508.1K
Travere Therapeutics, Inc.(TVTX)055,800+55,800$0$501.6K0.15%+$501.6K
89bio Inc044,500+44,500$0$497.1K0.15%+$497.1K
Zentalis Pharmaceuticals, Inc.(ZNTL)032,400+32,400$0$490.9K0.15%+$490.9K
Relay Therapeutics, Inc.(RLAY)042,400+42,400$0$466.8K0.14%+$466.8K
Arcus Biosciences, Inc.(RCUS)023,700+23,700$0$452.7K0.14%+$452.7K
MacroGenics, Inc.(MGNX)043,800+43,800$0$421.4K0.13%+$421.4K
Arcturus Therapeutics Holdings Inc.(ARCT)013,100+13,100$0$413.0K0.13%+$413.0K
Allogene Therapeutics Inc0128,400+128,400$0$412.2K0.13%+$412.2K
Seres Therapeutics, Inc.(MCRB)0292,300+292,300$0$409.2K0.13%+$409.2K
Zymeworks Inc.(ZYME)038,700+38,700$0$402.1K0.12%+$402.1K
Agenus Inc.(AGEN)0469,600+469,600$0$388.8K0.12%+$388.8K
Sage Therapeutics Inc017,500+17,500$0$379.2K0.12%+$379.2K
Erasca, Inc.(ERAS)0166,200+166,200$0$354.0K0.11%+$354.0K
Agios Pharmaceuticals, Inc.(AGIO)015,100+15,100$0$336.3K0.10%+$336.3K
Enanta Pharmaceuticals, Inc.(ENTA)035,100+35,100$0$330.3K0.10%+$330.3K
uniQure N.V.SHS(QURE)048,500+48,500$0$328.3K0.10%+$328.3K
Getaround Inc1,348,1531,348,1530$470.5K$316.8K0.10%-$153.7K
Compass Therapeutics, Inc.(CMPX)0199,000+199,000$0$310.4K0.10%+$310.4K
Novavax, Inc.(NVAX)060,300+60,300$0$289.4K0.09%+$289.4K
Replimune Group, Inc.(REPL)030,500+30,500$0$257.1K0.08%+$257.1K
BioXcel Therapeutics, Inc.(BTAIQ)083,900+83,900$0$247.5K0.08%+$247.5K
Allovir Inc0215,700+215,700$0$146.6K0.05%+$146.6K
Bluebird Bio Inc087,400+87,400$0$120.6K0.04%+$120.6K
Airspan Networks Holdings In1,047,4731,047,4730$157.1K$94.3K0.03%-$62.8K
Grab Holdings LimitedW EXP 12 01 202
*W EXP 99/99/999
80,00080,0000$27.6K$18.0K0.01%-$9.6K
DISH NETWORK CORPORATIONCL A4,150,0000-4,150,000$24.32M$0—-$24.32M
Page 1 of 1
Pennant Investors, LP — 13F Holdings — Q4 2023 | TickerTrail